Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (661-670 of 992) with videos related to

Pageof 100
Sort By:
The Journal of Infectious Diseases|April 21, 2019
Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United KingdomRama Kandasamy, Merryn Voysey, Sarah Collins, et al.
Vaccine|October 2, 2024
Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trialMaia Patrick-Smith, Katherine Emary, Susanne H Hodgson, et al.
Journal of Tropical Pediatrics|April 20, 2013
Prevalence and genetic analysis of phenotypically Vi- negative Salmonella typhi isolates in children from Kathmandu, NepalAnoop S Pulickal, Martin J Callaghan, Dominic F Kelly, et al.
Plos Pathogens|May 23, 2015
Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge modelMonica A McArthur, Stephanie Fresnay, Laurence S Magder, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 12, 2018
Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgGSjoerd Rijpkema, Jason Hockley, Alastair Logan, et al.
BMJ Public Health|December 10, 2025
Mixed-methods study assessing the acceptability and feasibility of Human Challenge Studies for Disease X in Healthy UK Adults in a SARS-CoV-2 pandemic settingKatherine Rw Emary, Rebecca Te Water Naude, Arabella Stewart, et al.
BMJ Open|January 10, 2024
Protocol for the challenge non-typhoidal <i>Salmonella</i> (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UKChristopher Smith, Emma Smith, Anna Rydlova, et al.
The Pediatric Infectious Disease Journal|May 27, 2016
Density Distribution of Pharyngeal Carriage of Meningococcus in Healthy Young Adults: New Approaches to Studying the Epidemiology of Colonization and Vaccine Indirect EffectsAdam Finn, Begonia Morales-Aza, Paulina Sikora, et al.
The Journal of Infection|March 4, 2022
Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activityLeanne Marsay, Christina Dold, Gavin K Paterson, et al.
Human Vaccines & Immunotherapeutics|May 4, 2023
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccinesTonia M Thomas, Susanne H Hodgson, Katherine Emary, et al.
Pageof 100

Showing results (661-670 of 992) with videos related to

Sort By:
Pageof 100
The Journal of Infectious Diseases|April 21, 2019
Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United KingdomRama Kandasamy, Merryn Voysey, Sarah Collins, et al.
Vaccine|October 2, 2024
Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trialMaia Patrick-Smith, Katherine Emary, Susanne H Hodgson, et al.
Journal of Tropical Pediatrics|April 20, 2013
Prevalence and genetic analysis of phenotypically Vi- negative Salmonella typhi isolates in children from Kathmandu, NepalAnoop S Pulickal, Martin J Callaghan, Dominic F Kelly, et al.
Plos Pathogens|May 23, 2015
Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge modelMonica A McArthur, Stephanie Fresnay, Laurence S Magder, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 12, 2018
Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgGSjoerd Rijpkema, Jason Hockley, Alastair Logan, et al.
BMJ Public Health|December 10, 2025
Mixed-methods study assessing the acceptability and feasibility of Human Challenge Studies for Disease X in Healthy UK Adults in a SARS-CoV-2 pandemic settingKatherine Rw Emary, Rebecca Te Water Naude, Arabella Stewart, et al.
BMJ Open|January 10, 2024
Protocol for the challenge non-typhoidal <i>Salmonella</i> (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UKChristopher Smith, Emma Smith, Anna Rydlova, et al.
The Pediatric Infectious Disease Journal|May 27, 2016
Density Distribution of Pharyngeal Carriage of Meningococcus in Healthy Young Adults: New Approaches to Studying the Epidemiology of Colonization and Vaccine Indirect EffectsAdam Finn, Begonia Morales-Aza, Paulina Sikora, et al.
The Journal of Infection|March 4, 2022
Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activityLeanne Marsay, Christina Dold, Gavin K Paterson, et al.
Human Vaccines & Immunotherapeutics|May 4, 2023
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccinesTonia M Thomas, Susanne H Hodgson, Katherine Emary, et al.
Pageof 100